Results 21 to 30 of about 2,152,009 (360)

Post-hoc analysis of Arabic transformer models

Proceedings of the Fifth BlackboxNLP Workshop on Analyzing and Interpreting Neural Networks for NLP, 2022
BlackboxNLP 2022.
Abdelali, Ahmed, Durrani, Nadir, Dalvi, Fahim, Sajjad, Hassan   +3 more
openaire   +2 more sources

An Automatic Motion-Based Artifact Reduction Algorithm for fNIRS in Concurrent Functional Magnetic Resonance Imaging Studies (AMARA–fMRI)

Algorithms, 2023
Multimodal functional near-infrared spectroscopy–functional magnetic resonance imaging (fNIRS–fMRI) studies have been highly beneficial for both the fNIRS and fMRI field as, for example, they shed light on the underlying mechanism of each method. However,
Lia Maria Hocke, Yunjie Tong, Blaise deBonneval Frederick   +2 more
doaj   +1 more source

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial

Diabetes, obesity and metabolism, 2022
To perform a post hoc analysis of the FIGHT trial, evaluating the effect of liraglutide (vs. placebo) on the totality of events in patients with heart failure with reduced ejection fraction (HFrEF).
J. Neves, F. Vasques-Nóvoa, M. Borges-Canha, A. Leite, Abhinav Sharma, D. Carvalho, M. Packer, F. Zannad, A. Leite-Moreira, João Pedro Ferreira   +9 more
semanticscholar   +1 more source

Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.

JAMA ophthalmology, 2022
Importance Antifungal resistance has been shown to impact treatment success, but research analyzing antifungal resistance is scarce. Objective To evaluate changes in antifungal resistance over time.
N. V. Prajna, P. Lalitha, Tiruvengada Krishnan, Revathi Rajaraman, Naveen Radnakrishnan, M. Srinivasan, Lumbini Devi, M. Das, Zijun Liu, M. Zegans, N. Acharya, T. Porco, T. Lietman, Jennifer Rose-Nussbaumer   +13 more
semanticscholar   +1 more source

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

Clinical Kidney Journal, 2022
Background Mineralocorticoid receptor antagonists (MRAs) reduce systolic blood pressure (SBP) and increase serum potassium concentration ([K+]).
R. Agarwal, B. Pitt, B. Palmer, C. Kovesdy, Ellen Burgess, G. Filippatos, J. Małyszko, L. Ruilope, P. Rossignol, P. Rossing, R. Pecoits-Filho, S. Anker, A. Joseph, R. Lawatscheck, D. Wilson, M. Gebel, G. Bakris   +16 more
semanticscholar   +1 more source

Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial

Biomolecules, 2021
In a previous randomized trial, the non-inferiority of two hyaluronic acid injections (Synolis VA versus Synvisc-One) was assessed in patients with knee OA, with a response rate of 79% for Synolis VA.
Olivier Bruyère, Germain Honvo, Eduard Vidovic, Bernard Cortet   +3 more
doaj   +1 more source

Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial

PLoS ONE, 2021
Background Beyond antihyperglycemic effects, metformin may improve cardiovascular outcomes. Patients with type 2 diabetes often have an elevated plasma level of N-terminal pro B-type as a marker of (sub) clinical cardiovascular disease.
W. Top, P. Lehert, C. Schalkwijk, C. Stehouwer, A. Kooy   +4 more
semanticscholar   +1 more source

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis

Diabetes, obesity and metabolism, 2021
In a phase 2 trial of once‐weekly tirzepatide (1, 5, 10, or 15 mg), dulaglutide (1.5 mg), or placebo, the dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide dose‐dependently reduced HbA1c and body ...
Jonathan M. Wilson, Yanzhu Lin, M. Jane Luo, Gary Considine, Amy L. Cox, Lenden M. Bowsman, D. Robins, A. Haupt, Kevin L Duffin, G. Ruotolo   +9 more
semanticscholar   +1 more source

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study

Journal of Asthma and Allergy, 2021
Background Tezepelumab is a human monoclonal antibody that blocks thymic stromal lymphopoietin, an epithelial cytokine implicated in asthma pathogenesis, from binding to its heterodimeric receptor. In the phase 2b PATHWAY study, tezepelumab significantly
C. Emson, J. Corren, K. Salapa, A. Hellqvist, J. Parnes, G. Colice   +5 more
semanticscholar   +1 more source

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

Diabetes Care, 2021
OBJECTIVE A post hoc analysis to investigate the association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events.
F. Persson, S. Bain, Ofri Mosenzon, H. Heerspink, J. Mann, R. Pratley, I. Raz, Thomas Idorn, S. Rasmussen, Bernt Johan von Scholten, P. Rossing   +10 more
semanticscholar   +1 more source